Last year, the FDA approved the biologic drug Dupixent to treat uncontrolled eosinophilic COPD. The approval marked a step ...

More people may be at risk for developing COPD due to exposure to environmental irritants, such as heat waves and air ...

LCMC Health is proud to announce that three different units at two of their hospitals have received Beacon Award Designations ...

Increased perceived stress may cause worsened respiratory symptoms and decreased quality of life in people with chronic obstructive pulmonary disease (COPD), according to a new study.

Climate change is affecting the health of all individuals and represents an even more significant health risk for individuals with COPD.

Nottinghamshire Healthcare’s community respiratory nurses are excited to pilot a brand new programme for patients with newly ...

For patients with complex needs and social challenges like unstable housing, the hospital has become their de facto medical ...

Leading specialists in pulmonology have formed Healio Pulmonology’s Peer Perspective Board to help guide coverage and provide ...

Medicaid beneficiaries face higher rates of pulmonary hypertension, with significant economic burdens and racial disparities in prevalence and costs.

As Sanofi anticipates sales of immunotherapy juggernaut Dupixent reaching a major $22 billion by the end of the decade, ...

Although the definition of acute respiratory distress syndrome (ARDS) has undergone numerous revisions aimed at enhancing its diagnostic accuracy and clinical practicality, the usefulness and ...